Is Rifampin Capsule in shortage?
Yes. Rifampin Capsule is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.
Why it’s in shortage
- Discontinuation of the manufacture of the drug
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Rifampin, Capsule, 300 mg (NDC 42806-799-01)
Discontinuation of the manufacture of the drug
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 300 mg (NDC 42806-799-05)
Discontinuation of the manufacture of the drug
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 300 mg (NDC 42806-799-30)
Discontinuation of the manufacture of the drug
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 300 mg (NDC 42806-799-60)
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 150 mg (NDC 42806-801-01)
Discontinuation of the manufacture of the drug
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 150 mg (NDC 42806-801-30)
Maker contact: (718) 276-8600 ext. 3
- Rifampin, Capsule, 150 mg (NDC 68180-658-06)
Maker contact: 866-587-4617
- Rifampin, Capsule, 300 mg (NDC 68180-659-06)
Maker contact: 866-587-4617
- Rifampin, Capsule, 300 mg (NDC 68180-659-07)
Maker contact: 866-587-4617
FDA recalls of Rifampin
Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Rifampin Capsule:
- Amerisource Health Services LLC recalls Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health
- Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
- Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore,
- Amerisource Health Services LLC recalls Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging,
- Lupin Pharmaceuticals Inc. recalls Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland
- Lupin Pharmaceuticals Inc. recalls Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Lupin Pharmaceuticals, Inc.,
- Mylan Pharmaceuticals Inc recalls Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC,
- Mylan Laboratories Limited (Sterile Products Division) recalls Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC
- Fresenius Kabi USA, LLC recalls Rifampin for Injection, USP 600mg/vial in a 20mL vial, Rx only, Manufactured for Fresenius Kabi LLC 3 Corporate Drive,
Other forms on FDA’s list
Rifampin Capsule shortage questions
Is Rifampin Capsule in shortage?
Yes. Rifampin Capsule is on FDA’s drug shortage list (unavailable), last updated Oct 5, 2026.
Why is there a Rifampin Capsule shortage?
FDA records the reason as: Discontinuation of the manufacture of the drug.
What should I do if I can’t get Rifampin Capsule?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.